Dr. Hunter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 Forrest Crossing Blvd
Suite 103
Franklin, TN 37064Phone+1 615-791-5470Fax+1 615-595-0265- Is this information wrong?
Education & Training
Mayo Clinic College of Medicine and ScienceFellowship, Clinician Investigator Training Program, 1995 - 1997- Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1992 - 1995
- Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 1991 - 1992
University of Texas Medical Branch GalvestonPhD, Pharmacology-Toxicology, 1984 - 1991
University of Texas Medical Branch School of MedicineClass of 1991- University of Helsinkipostgraduate, Pharmacology/Physiology, ITT International Fellow/Flubright Award, 1983 - 1984
- Oral Roberts UniversityBS, Biology, Computer Science, Mathematics, Chemistry, Summa Cum Laude, 1979 - 1983
Certifications & Licensure
TN State Medical License 1997 - 2025
FL State Medical License 2015 - 2017
TX State Medical License 1993 - 1998
MN State Medical License 1992 - 1997- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
- Immunodeficiency in MS Start of enrollment: 2020 Jun 29
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsEndocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies.Colin M Dayan, Beatriz Lecumberri, Ilaria Muller, Sashiananthan Ganesananthan, Samuel F Hunter, Krzysztof W Selmaj, Hans-Peter Hartung, Eva K Havrdova, Christopher C L...> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2023 Jan 3
- Arbaclofen extended-release tablets for spasticity in multiple sclerosis: open-label extension study.Darin T Okuda, Daniel Kantor, Mark Jaros, Tina deVries, Samuel Hunter> ;Brain Communications. 2023 Jan 1
- 3 citationsSatisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study.Sibyl Wray, Francois Jacques, Tamara A Miller, Jacqueline A Nicholas, Rafael Arroyo, Lori Travis, Bhupendra Khatri, Magdalena Chirieac, Roopali Gandhi, Nora Roesch, Am...> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2022 Nov 15
- Join now to see all
Press Mentions
Preparing for #ACTRIMS2017 – Top 3 Topics from ACTRIMS 2016April 26th, 2017
Professional Memberships
- Member
Hospital Affiliations
Williamson Medical CenterFranklin, Tennessee
Ascension Saint ThomasNashville, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
